Physiologic versus neoplastic C-cell hyperplasia of the thyroid: Separation of distinct histologic and biologic entities

Cancer

Volumn 77, Issue 4, 1996, Pages 750-756

  Perry, Arrie ^a   Molberg, Kyle ^a   Albores Saavedra, Jorge ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

familial medullary carcinoma; immunohistochemistry; medullary carcinoma in situ; MEN IIa; MEN IIb; physiologic C cell hyperplasia

Indexed keywords

CALCITONIN;

ADOLESCENT; ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE MUTATION; HASHIMOTO DISEASE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; THYROID ADENOMA; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; BASEMENT MEMBRANE; CALCITONIN; CARCINOMA IN SITU; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; COLORING AGENTS; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; THYROIDITIS, AUTOIMMUNE;

EID: 0030063766     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960215)77:4<750::AID-CNCR22>3.0.CO;2-Z     Document Type: Article

References (44)

1. Pearse AGE. The cytochemistry of the thyroid C-cells and their relationship to calcitonin. Proc R Soc Land B Biol Sci 1966;164:478-87.
2. Hazard JB, Hawk WA, Crile G. Medullary (solid) carcinoma of the thyroid: a clinicopathologic entity. J Clin Endocrinol Metab 1959;19:152-61.
3. Albores-Saavedra J, LiVolsi VA, Williams ED. Medullary carcinoma. Semin Diagn Pathol 1985;2:137-46.
4. Al Saadi AA. Ultrastructure in C-cell hyperplasia in asymptomatic patients with hypercalcitoninemia and a family history of medullary thyroid carcinoma. Hum Pathol 1981; 12:617-22.
5. Biddinger PW, Ray M. Distribution of C-cells in the normal and diseased thyroid gland. Pathol Annu 1993;28:205-29.
6. Carney JA, Sizemore GW, Hales AB. Multiple endocrine neoplasia, type 2b. Pathobiol Annu 1978;8:105-53.
7. DeLellis RA, Wolfe HJ. The pathobiology of the human calcitonin (C)-cell; a review. Pathol Annu. 1981;16:25-52.
8. Ekblom M, Valimaki M. Pelkonen R, Jansson R, Sivula A, Franssila K. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistochemical findings. QJ Med 1987;65:899-910.
9. Hazard JB. The C-cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. Am J Pathol 1977;88:214-49.
10. Mendelsohn G, Eggleston JC, Weisburger WR, Gann DS, Baylin SB. Calcitonin and histaminase in C-cell hyperplasia and medullary thyroid carcinoma. A light microscopic and immunohistochemical study. Am J Pathol 1978;92:35-52.
11. Simpson WJ, Carruthers JS, Malkins D. Results of a screening program for C-cell disease (medullary thyroid cancer and C-cell hyperplasia). Cancer 1990;65:1570-6.
12. Uribe M, Grimes M, Fenoglio-Preiser CM, Feind C. Medullary carcinoma of the thyroid gland. Am J Surg Pathol 1985;9:577-94.
13. Williams ED, Ponder BJ, Craig RK. Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia. Clin Endocrinol 1987;27:107-14.
14. Wolfe HJ, Melvin KEW, Cervi-Skinner SJ, Al Saadi AA, Julian JF, Jackson CE, Tashjian AH Jr. C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 1973;289:437-41.
15. Gibson WGH, Peng TC, Croker BP. C-cell nodules in adult human thyroid. A common autopsy finding. Am J Clin Pathol 1981;75:347-50.
16. Gibson WGH, Peng TC, Croker BP. Age-associated C-cell hyperplasia in the human thyroid. Am J Pathol 1982; 106:388-93.
17. Tomita T, Millard DM. C-cell hyperplasia in secondary hyperparathyroidism. Histopathology 1992;21:469-74.
18. Ljungberg O, Dymling JF. Pathogenesis of C-cell neoplasia in thyroid gland. Acta Pathol Microbiol Scand A 1972;80:577-88.
19. Albores-Saavedra J. C-cell hyperplasia [letter]. Am J Surg Pathol 1989;13:987.
20. Barbot N, Guyetant S, Beldent V, Akrass A, Cerf I, Perdrisot R, et al. Chronic autoimmune thyroiditis and C-cell hyperplasia. Study of calcitonin secretion in 24 patients. Ann Endocrinol (Paris). 1991;52(2):109-12.
21. Baschieri L, Castagna M, Fierabracci A, Antonelli A, Del Guerra P, Squartini F. Distribution of calcitonin- and somatostatin-containing cells in thyroid lymphoma and in Hashimoto's thyroiditis. Appl Pathol 1989;7:99-104.
22. Biddinger PW, Brennan MF, Rosen PP. Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. Am J Surg Pathol 1991;15:599-604.
23. Libbey NP, Nowakowski KJ, Tucci JR. C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis. Am J Surg Pathol 1989;13:71-7.
24. Ulbright TM, Kraus FT, O'Neal LW. C-cell hyperplasia developing in residual thyroid following resection for sporadic medullary carcinoma. Cancer 1981;48:2076-9.
25. Albores-Saavedra J, Monforte H, Nadji M, Morales AR. C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 1988;19:795-9.
26. Scopsi L, DiPalma S, Ferrari C, Holst JJ, Rehfeld JF, Rilke F. C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostanin. Mod Pathol 1991;4:297-304.
27. LiVolsi VA, Feind CR, LoGerfo P, Tashjian AH Jr. Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism. J Clin Endocrinol Metab 1973;37:550-59.
28. Aliapoulios MA, Kacoyanis GP. Thyroid stimulating hormone and thyrocalcitonin content in rat thyroid. J Surg Res 1976;21:449-52.
29. Clark OH, Rehfeld SJ, Castner B, Stroop J, Loken HF, Deftos LJ. Iodine deficiency produces hypercalcemia and hypercalcitoninemia in rats. Surgery 1978;83:626-32.
30. Peng TC, Cooper CW, Garner SC, Volpert EM. Hypercalcitonism and C-cell hyperplasia in rats with goiters produced by a low iodine diet or propylthiouracil. Pharmacol Exp Ther 1978;206:710-7.
31. Peng TC, Cooper CW, Petrusz P, Volpert EM. Identification of C-cells in normal and goitrous rat thyroid tissues using antiserum to rat thyrocalcitonin and the immunoperoxidase bridge technique. Endocrinology 1975;97:1537-44.
32. Yasumura S, Burk M, Chausmer A, Mittleman R, Wallach S. Thyroidal content of thyrocalcitonin in hypothyroid and hyperthyroid rats. Endocrinology 1967;81:256-60.
33. Gkonos PJ, Tavianini MA, Liu CC, Roos BA. Thyrotropinreleasing hormone gene expression in normal thyroid parafollicular cells Mol Endocrinol 1989;3:2101-9.
34. Shimotake T, Iwai N, Yanagihara J, Tikiwa K, Tamapa N, Yamamoto M, et al. Prediction of affected MEN 2A gene carriers by DNA linkage analysis for early total thyroidectomy. a progress in clinical screening program for children with hereditary cancer syndrome. J Pediatr Surg 1992; 27:444-6.
35. Howe JR, Lairmore TC, Mishra SK, Dou S, Veile R, Wells SA Jr., et al. Improved predictive test for MEN 2, using flanking dinucleotide repeats and RFLPs. Am J Hum Genet 1992;51:1430-42.
36. Lairmore TC, Howe JR, Korte JA, Dilley WG, Aine L, Aine E, et al. Familial medullary thyroid carcinoma and multiple endocrine neoplasm type 2b map to the same region of chromosome 10 as multiple endocrine neoplasia type 2a. Genomics 1991;9:181-92.
37. Mulligan LM, Gardner E, Smith BA, Mathew CGP, Ponder BAJ. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2. Genes Chromosom Cancer 1993;6:166-77.
38. Narod SA, Sobol H, Schuffenecker I, Lavorre MF, Lenoir GM. The gene for MEN 2A is tightly linked to the centromere of chromosome 10. Hum Genet 1991;88:529-30.
39. Thakker RV. The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol 1993;38:1-14.
40. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363:458-60.
41. Lips CJM, Landsvater RM, Höppener JWM, Geerdink RA, Blijham G, lansen-Schillhorn von Veen JM, et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 1994;331:828-35.
42. Komminoth P, Kunz EK, Matias-Guiu X, Hiort O, Christiansen G, Colomer A, et al. Analysis of RET protooncogenepoint mutations distinguishes heritable from nonheritablemedullary thyroid carcinomas. Cancer 1995;76:479-89.
43. Komminoth P, Roth J, Saremaslani P, Matias-Guiu X, Wolfe HJ, Heitz PU. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. Am J Surg Pathol 1994;18:399-411.
44. Matias-Guiu X, Peiro G, Esquius J, Oliva E, Cabezas R, Colomer A, et al. Proliferative activity in C-cell hyperplasia and medullary thyroid carcinoma. Evaluation by PCNA immunohistochemistry and AgNORs staining. Pathol Res Pract 1995;191:42-7.